More Business Wire
View Older Stories View Newer Stories-
NordVPN Partners with Noju to Expand Access Through Direct Carrier Billing
-
Glasshouse Fragrances Takes Inspiration From Canada’s Wild Beauty With the Launch of New ‘Northern Peaks’ Fragrance Collection
-
Kodiak Gas Services Announces Public Offering of Common Stock by Selling Stockholder
-
ICE Mortgage Monitor: Property Insurance Costs Grow 11.3% over the Last Twelve Months
-
Forward Industries, Inc. Announces $1.65 Billion Private Placement in Cash and Stablecoin Commitments Led by Galaxy Digital, Jump Crypto, and Multicoin Capital to Initiate Solana Treasury Strategy
-
Lunda Construction Awarded $19.7 Million I-41 Bridges Project in Wisconsin
-
CareTrust REIT to Participate in the Bank of America 2025 Global Real Estate Conference
-
Compa and WTW Announce a Partnership to Provide Compensation Intelligence for Enterprise Comp Teams
-
Walker & Dunlop Originates $68 Million in HUD Loans for Seven Skilled Nursing Facilities in Illinois and Wisconsin
-
Atom Therapeutics Announces Positive Topline Results of Lingdolinurad (ABP-671) in Phase 2b/3 Trial for Chronic Gout
-
Hopae and INCERT Partner to Make Hopae Connect the First EU-Registered Intermediary for a wide adoption and use of EU Digital Identity Wallet
-
Anaergia Announces Agreement to Provide EPC and O&M Services for Project in Riverside, California
-
IFF expands LMR Naturals site in Grasse, advancing naturals innovation leadership
-
Slomin’s Home Security Launches ShieldLink: The All-in-One Smart Home & Security Platform, Now Available Nationwide
-
Morgan Stanley Investment Management Raises JPY131 Billion for North Haven Real Estate Japan Strategy Fund I
-
Havas Reports the Progress of Transactions Under Its Current Share Buyback Program
-
Expro Sets Offshore World Record with Heaviest Casing String Deployment
-
MultiStrat Continues to Execute on Growth Plan With Capital Raise
-
Houlihan Lokey Further Expands EMEA Financial Sponsors Coverage With Senior Hire
-
Samsung Display Expands OLED Leadership into Mobility at IAA MOBILITY 2025
-
Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025
-
Jordana Semaan Appointed Chief of Staff, Middle East & Asia-Pacific of ZCG Arabia
-
$1 Million Awarded To Social Impact Student Start-Up At Global 2025 Hult Prize
-
NEP Europe's New OB Facilities Combine Innovation and Comfort for Premier League Coverage
-
Circus SE Begins Deliveries of AI-Robots from High-Volume Factory
-
JR CENTRAL RETAILING PLUS: Launch of Jointly-Designed Products Between Planes and Shinkansen Trains at Tokaido Shinkansen Station Stores!
-
Getlink SE: Shuttle Traffic in August 2025
-
Locate Bio Expands RESTORE Clinical Study to the United States Following FDA IDE Approval
-
Autonomous Driving Innovator QCraft Globalizes With European HQ and Forms Partnership With Qualcomm
-
CMP Scientific Announces Dr. Darlene Solomon to Advise on Strategy and Technology
-
Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025
-
Ayar Labs and Alchip to Scale AI Infrastructure With Co-Packaged Optics
-
Hidetaka Kokubu Appointed as Head of Japan at Xsolla
-
HuneX Launches “AI Gallery” on Android — Three AI-generated Art Series Featuring Beautiful Japanese Women Now Available
-
Gunze Uses Proprietary Calculation Technology to Visualize the Contribution of Greening Projects to Reducing Carbon Dioxide Absorption
-
Triangle Life releases Private Purpose: A New Lens on How the Global Wealthy Define and Drive Positive Impact
-
Semtech Unveils High-Performance TIAs for 1.6T AI Data Centers
-
Ifinatamab Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial
-
Fresenius Kabi and AABB Announce 20th Anniversary of Blood Collectors Week, September 7–14, 2025, Honoring Lifesaving Blood Collection Professionals
-
RH to Report Second Quarter Fiscal 2025 Financial Results on September 11, 2025
-
TAGRISSO® (osimertinib) plus chemotherapy demonstrated a median overall survival of nearly four years, the longest benefit ever reported in a global Phase III trial in EGFR-mutated advanced lung canc
-
Nuvation Bio Announces New Data from Pivotal Clinical Studies of IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer
-
Longer-Term Follow-Up of Western Patients Showed Improving, Favorable Trend in Overall Survival in Global Phase III HARMONi Clinical Trial for Ivonescimab Plus Chemotherapy in 2L+ EGFRm NSCLC
-
SenseRobot Unveils Chess Mini Demo at IFA 2025
-
CUPE: Air Canada flight attendants reject Air Canada's wage offer
-
World Lab Technologies Establishes New Standard for Capital Integrity and Enforceable Governance
-
Hongqi at IAA: With Localized Strategy and Commitment to Safety & Reliability, to Debut the Latest Electric SUV
-
Singapore Festival 2025: A First-of-its-Kind Celebration of Culture, Community, and 60 Years of Nationhood
-
Douglas Emmett Declares Quarterly Cash Dividend
-
U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
